STOCK TITAN
  1. Home
  2. Sec-filings
  3. BATRA
  4. [Form 4] Atlanta Braves Holdings, Inc. Insider Trading Activity

BATRA EVP exercised 20,000 options at $27.18 and sold same day

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Atlanta Braves Holdings insider Jill L. Robinson, who is listed as EVP, CFO & Treasurer, executed two related transactions on 10/01/2025. She exercised a stock option to acquire 20,000 Series C common shares at an exercise price of $27.18, and on the same day sold 20,000 Series C common shares under a Rule 10b5-1 sales plan adopted May 15, 2025, at a weighted-average sale price of $40.998 (reported range $40.81–$41.18. After the transactions the filings show 68,755 Series C shares owned directly and 130,263 total Series C shares beneficially owned as reported in the derivative table.

Positive

  • 20,000 Series C shares were acquired by exercise at a $27.18 strike price
  • Sale executed under a documented Rule 10b5-1 sales plan adopted May 15, 2025

Negative

  • 20,000 Series C shares were sold on 10/01/2025 at a weighted-average price of $40.998
  • Post-transaction direct ownership of Series C shares decreased to 68,755

Insights

TL;DR: Executive exercised options and sold an identical number of shares under a 10b5-1 plan on 10/01/2025.

Jill L. Robinson exercised a stock option to buy 20,000 Series C shares at $27.18 and sold 20,000 Series C shares the same day under a Rule 10b5-1 plan at a weighted-average price of $40.998. The filing explicitly states the sales were effected pursuant to the 10b5-1 plan adopted on May 15, 2025.

Because these actions are disclosed on Form 4 and tied to a pre-arranged plan, they are routine insider-disclosure activity recorded per Section 16; the filing does not state any additional context, intent, or material nonpublic information.

Insider Robinson Jill L.
Role EVP, CFO & Treasurer
Sold 20,000 shs ($820K)
Approx. gross sale proceeds $820K
Approx. exercise cost $544K
Approx. pre-tax spread $276K
Type Security Shares Price Value
Exercise Stock option (Right to Buy) - BATRK 20,000 $0.00 --
Exercise Series C Common Stock 20,000 $27.18 $544K
Sale Series C Common Stock 20,000 $40.998 $820K
Holdings After Transaction: Stock option (Right to Buy) - BATRK — 130,263 shares (Direct); Series C Common Stock — 68,755 shares (Direct)
Footnotes (2)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025.
  2. F2. Reflects the weighted average sale price. The range of prices for such transaction is $40.81 to $41.18. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Atlanta Braves Holdings insider Jill L. Robinson do on 10/01/2025 (BATRA)?
She exercised a stock option for 20,000 Series C shares at $27.18 and sold 20,000 Series C shares under a 10b5-1 plan at a weighted-average price of $40.998.

Was the sale covered by a pre-arranged plan for BATRA insider trading?
Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 sales plan adopted on May 15, 2025.

What prices were disclosed for the shares sold by the reporting person?
The Form 4 reports a weighted-average sale price of $40.998 with a reported range of $40.81 to $41.18.

How many Series C shares does the reporting person own after these transactions?
The filing shows 68,755 Series C shares owned directly after the transactions and 130,263 Series C shares listed in the derivative table as beneficially owned.

What is the relationship of the reporting person to Atlanta Braves Holdings (BATRA)?
The Form 4 identifies Jill L. Robinson as a company Officer with the title EVP, CFO & Treasurer.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Robinson Jill L.
(Last) (First) (Middle)
C/O ATLANTA BRAVES HOLDINGS, INC.
755 BATTERY AVENUE SE
(Street)
ATLANTA GA 30339
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CFO & Treasurer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Series C Common Stock 10/01/2025 M 20,000 A $27.18 88,755 D
Series C Common Stock 10/01/2025 S(1) 20,000 D $40.998(2) 68,755 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (Right to Buy) - BATRK $27.18 10/01/2025 M 20,000 12/10/2023 12/10/2027 Series C Common Stock 20,000 $0 130,263 D
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025.
2. Reflects the weighted average sale price. The range of prices for such transaction is $40.81 to $41.18. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
/s/ Kerry T. Wenzel, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR